Publications by authors named "DaZhao Mi"

Claim this Profile
L
LN-439A, a novel BAP1 inhibitor, suppresses the growth of basal-like breast cancer by degrading KLF5.
Tian-Tian Wang, Long-Long Zhang, Fu-Bing Li, Jie Zhang, Zhi-Bi Zhang, Da-Zhao Mi

Acta Pharmacol Sin· March 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
D
Discovery of novel BCL6-Targeting PROTACs with effective antitumor activities against DLBCL in vitro and in vivo.
Dazhao Mi, Cheng Li, Yuzhan Li, Mingyue Yao, Yan Li

Eur J Med Chem· November 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
T
Targeting PRMT5 through PROTAC for the treatment of triple-negative breast cancer.
Yaxun Guo, Yuzhan Li, Zhongmei Zhou, Lei Hou, Wenjing Liu, Dazhao Mi

J Exp Clin Cancer Res· November 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
A long march for targeted protein degradation in the new era: expanding E3 ligases.
Dazhao Mi, Anxin Huang, Jingfeng Song, Yihua Chen

Future Med Chem· October 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
D
Discovery of a Highly Potent and Selective MYOF Inhibitor with Improved Water Solubility for the Treatment of Gastric Cancer.
Haijun Gu, Ting Zhang, Tian Guan, Min Wu, Shen Li, Dazhao Mi, Mingyao Liu

J Med Chem· December 2023

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
Current advances of small molecule E3 ligands for proteolysis-targeting chimeras design.
Dazhao Mi, Yuzhan Li, Haijun Gu, Yan Li, Yihua Chen

Eur J Med Chem· August 2023

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
Corrigendum to "Discovery of YH677 as a cancer stemness inhibitor that suppresses triple-negative breast cancer growth and metastasis by regulating the TGFβ signaling pathway" [Canc. Lett. (2023) 216142].
Yuzhu Zhang, Jing Chen, Dazhao Mi, Jun Ling, Huachao Li

Cancer Lett· July 2023

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
D
Discovery of Pyrimidinediamine Derivatives as Potent Methuosis Inducers for the Treatment of Triple-Negative Breast Cancer.
Jia He, Luzhen Wang, DaZhao Mi, Tian Guan, Wenjing Liu

J Med Chem· June 2023

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
D
Discovery of YH677 as a cancer stemness inhibitor that suppresses triple-negative breast cancer growth and metastasis by regulating the TGFβ signaling pathway.
Yuzhu Zhang, Jing Chen, Dazhao Mi, Jun Ling, Huachao Li

Cancer Lett· April 2023

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
S
Small-molecule Modulators Targeting SHP2 for Cancer Therapy.
Dazhao Mi, Yuzhan Li, Yihua Chen

Anticancer Agents Med Chem· March 2023

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
A novel methuosis inducer DZ-514 possesses antitumor activity via activation of ROS-MKK4-p38 axis in triple negative breast cancer.
Luzhen Wang, Dazhao Mi, Jinhui Hu, Wenjing Liu, Yi Zhang

Cancer Lett· February 2023

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
An instructive attempt on developing aptamer-constructed PROTAC for breast cancer treatment.
Yuzhu Zhang, Dazhao Mi, Yihua Chen

Mol Ther Nucleic Acids· December 2022

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
B
B-cell Lymphoma 6 Inhibitors: Current Advances and Prospects of Drug Development for Diffuse Large B-cell Lymphomas.
Haijun Gu, Jia He, Yuzhan Li, Dazhao Mi, Tian Guan

J Med Chem· December 2022

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
I
In vivo target protein degradation induced by PROTACs based on E3 ligase DCAF15.
Liang Li, Dazhao Mi, Haixiang Pei, Qiuhui Duan, Xinyue Wang, Mingyao Liu

Signal Transduct Target Ther· July 2020

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
M
Modification and Biological Evaluation of a Series of 1,5-Diaryl-1,2,4-triazole Compounds as Novel Agents against Pancreatic Cancer Metastasis through Targeting Myoferlin.
Yunqi Li, Yuan He, Ting Shao, Haixiang Pei, Weikai Guo, Dazhao Mi, Mingyao Liu

J Med Chem· May 2019

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis